Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 425-180-1 | CAS number: 66170-10-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1997-06-02 to 1997-07-18
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- adopted July 17, 1992
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Version / remarks:
- 96/54/EC
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- -
- EC Number:
- 425-180-1
- EC Name:
- -
- Cas Number:
- 66170-10-3
- Molecular formula:
- C6H6O9P.3Na
- IUPAC Name:
- trisodium (2R)-2-[(1S)-1,2-dihydroxyethyl]-5-oxo-4-(phosphonatooxy)-2,5-dihydrofuran-3-olate
- Details on test material:
- - Name of test material (as cited in study report): Sodium ascorbyl phosphate
- Physical state: Powder, beige
- Analytical purity: 85.4 g/100 g (HPLC)
- Date of Manufacturing: 1997-05-02
- Lot/batch No.: 28600/37-9
- Stability under test conditions: The stability of the test substance in aqua bidest. for a time period of 96 hours was confirmed by analysis
- Storage condition of test material: Room temperature
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Pirbright-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River GmbH - Wiga, Kisslegg, Germany
- Age at study initiation: Young adult animals
- Weight at study initiation: 320 - 394 g
- Housing: 5 animals per cage (Makrolon, type IV), Bedding: Granulat Type 3/4 (staubfrei) SSNIFF
- Diet: Kliba Labordiät 341 (Kaninchen-Meerschweinchen-Haltungsdiät) ad libitum
- Water: Water ad libitum (tap water; about 2 g of ascorbic acid per 10 L water was added to the drinking water twice a week)
- Acclimation period: 7 days before the beginning of the study in the laboratory for dermal toxicity
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24 °C
- Humidity (%): 30-70 %
- Photoperiod (hrs dark / hrs light): 12 h light (6.00 a.m. - 6.00 p.m.), 12 h darkness (6.00 p.m. - 6.00 a.m.)
IN-LIFE DATES: From: 1997-06-10 To: 1997-07-11
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- other: intradermal and percutaneous occlusive
- Vehicle:
- water
- Concentration / amount:
- 50%
Challengeopen allclose all
- Route:
- other: intradermal and percutaneous occlusive
- Vehicle:
- water
- Concentration / amount:
- 50%
- No. of animals per dose:
- Pretest: 4
Main test: 10 (control), 30 (test group) - Details on study design:
- RANGE FINDING TESTS:
Amount applied:
2 x 2 cm filter paper strips containing the test substance (5 %, 10 %, 25 %, 50 %) formulation were applied to the skin of the flanks under an occlusive dressing. The filter paper strip was soaked in the test substance formulation. The dressing consisted of rubberized linen patches (4 x 4 cm from Russka), patches of Idealbinde (5 x 5 cm from Pfälzische Verbandstoff-Fabrik) and Fixomull®D Stretch (adhesive fleece) from Beiersdorf AG.
Exposure period:
The test substance was applied 2 times for 24 hours within a period of 96 hours in order to detect nonspecific phenomena that are not caused by a sensitization reaction but could possibly be attributed to a shift in the irritation threshold.
Site of application:
- flank, respectively on the same area
Number of test animals:
- 4 per test concentration
Readings:
- about 24 and 48 h after the beginning of application
Assessment of skin findings (according to Draize, J.H. (1959) : Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics. The Association of Food and Drug Officials of the United States Austin, Texas)
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 6 intradermal injections in groups of two per animal
- Exposure period: 48 h
- Test groups:
A) front row: 2 injections each of 0.1 mL Freund's adjuvant without test substance emulsified with 0.9% aqueous NaCL-solution in a ratio of 1 :1
B) middle row: 2 injections each of 0.1 mL of the test substance formulation
C) back row: 2 injections each of 0.1 mL Freund's adjuvant / 0.9% aqueous NaCl-solution (1 : 1) with test substance
- Control group:
The animals were given the same injections (A, B,C) but without test substance, only with the formulating agent.
- Site: shoulder
- Duration: 48 h
- Concentrations: 2 x 4 cm filter paper strips containing the test substance (50%) formulation were applied to the skin of the shoulder under an occlusive dressing. The filter paper strip was soaked in the test substance formulation. The dressing consisted of rubberized linen patches (4 x 6 cm from Russka) and Fixomull® Stretch (adhesive fleece) from Beiersdorf AG. The control animals were not treated since the distilled water used as formulating agent was not expected to influence the result of the study.
B. CHALLENGE EXPOSURE
- No. of exposures: 2
- Day(s) of challenge: Day 14, Day 21
- Exposure period: 24 h
- Test and Control groups:
1st challenge:
- The test group and control group 1 were treated with the test substance formulation (control group 2 remained untreated).
2nd challenge:
- The test group and control groups 1 and 2 were treated with the test substance formulation.
- Site: intact flank
- Concentrations: 2 x 2 cm filter paper strips containing the test substance (50%) formulation were applied to the skin of the flank under an occlusive dressing. The filter paper strip was soaked in the test substance formulation. The dressing consisted of rubberized linen patches (4 x 4 cm from Russka), patches of Idealbinde (5 x 5 cm from Pfälzische Verbandstoff-Fabrik) and Fixomull®D Stretch (adhesive fleece) from Beiersdorf AG.
- Evaluation (hr after challenge): 24 and 48 h after the removal of the patch - Challenge controls:
- 1st challenge:
- The control group 1 was treated with the test substance formulation (control group 2 remained untreated).
2nd challenge:
- The control groups 1 and 2 were treated with the test substance formulation. - Positive control substance(s):
- yes
- Remarks:
- A positive control (reliability check) with Alpha-Hexylcinnamaldehyde is not included in this study. However, a separate study is performed twice a year in the laboratory.
Results and discussion
- Positive control results:
- A positive control (reliability check) with a known sensitizer is not included in this study. However, a separate study is performed twice a year in the laboratory.
The positive control with Alpha-Hexylcinnamaldehyde techn. 85% showed that the test system was able to detect sensitizing compounds under the laboratory conditions chosen.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- other: first challenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50 %
- No. with + reactions:
- 2
- Total no. in group:
- 23
- Clinical observations:
- 7 test group animals died 8, 9 or 10 days after the beginning of the study. Macroscopic examination revealed that animals suffered from pneumonia (not test substance treatment related). Well-defined, spotted erythema was observed in 2 test group animals.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: other: first challenge. . Hours after challenge: 24.0. Group: test group. Dose level: 50 %. No with. + reactions: 2.0. Total no. in groups: 23.0. Clinical observations: 7 test group animals died 8, 9 or 10 days after the beginning of the study. Macroscopic examination revealed that animals suffered from pneumonia (not test substance treatment related). Well-defined, spotted erythema was observed in 2 test group animals..
- Reading:
- other: first challenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 3
- Total no. in group:
- 23
- Clinical observations:
- 3 test group animals showed very slight, spotted erythema, 2 out of these animals additionally exhibited scaling. In 1 test group animal well defined, spotted erythema and scaling were noted.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: other: first challenge. . Hours after challenge: 48.0. Group: test group. Dose level: 50%. No with. + reactions: 3.0. Total no. in groups: 23.0. Clinical observations: 3 test group animals showed very slight, spotted erythema, 2 out of these animals additionally exhibited scaling. In 1 test group animal well defined, spotted erythema and scaling were noted..
- Reading:
- other: first challenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none (control group 1)
- Remarks on result:
- other: Reading: other: first challenge. . Hours after challenge: 24.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none (control group 1).
- Reading:
- other: first challenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none (control group 1)
- Remarks on result:
- other: Reading: other: first challenge. . Hours after challenge: 48.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none (control group 1).
- Reading:
- other: second challenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50 %
- No. with + reactions:
- 0
- Total no. in group:
- 23
- Remarks on result:
- other: Reading: other: second challenge. . Hours after challenge: 24.0. Group: test group. Dose level: 50 %. No with. + reactions: 0.0. Total no. in groups: 23.0.
- Reading:
- other: second challenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50 %
- No. with + reactions:
- 0
- Total no. in group:
- 23
- Remarks on result:
- other: Reading: other: second challenge. . Hours after challenge: 48.0. Group: test group. Dose level: 50 %. No with. + reactions: 0.0. Total no. in groups: 23.0.
- Reading:
- other: second challenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none (control group 1)
- Remarks on result:
- other: Reading: other: second challenge. . Hours after challenge: 24.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none (control group 1).
- Reading:
- other: second challenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none (control group 1)
- Remarks on result:
- other: Reading: other: second challenge. . Hours after challenge: 48.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none (control group 1).
- Reading:
- other: second challenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none (control group 2)
- Remarks on result:
- other: Reading: other: second challenge. . Hours after challenge: 24.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none (control group 2).
- Reading:
- other: second challenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none (control group 2)
- Remarks on result:
- other: Reading: other: second challenge. . Hours after challenge: 48.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none (control group 2).
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- Sodium ascorbyl phosphate is not a skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.